- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes ; day:21 ; month:11 ; year:2020 ; pages:1-13
Diabetes therapy ; (21.11.2020), 1-13
- Urheber
-
Gentile, Sandro
Guarino, Giuseppina
Della Corte, Teresa
Marino, Giampiero
Fusco, Alessandra
Corigliano, Gerardo
Colarusso, Sara
Piscopo, Marco
Improta, Maria Rosaria
Corigliano, Marco
Martedi, Emilia
Oliva, Domenica
Russo, Viviana
Simonetti, Rosa
Satta, Ersilia
Romano, Carmine
Vaia, Sebastiano
Strollo, Felice
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-020-00954-3
- URN
-
urn:nbn:de:101:1-2021010118590053656703
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gentile, Sandro
- Guarino, Giuseppina
- Della Corte, Teresa
- Marino, Giampiero
- Fusco, Alessandra
- Corigliano, Gerardo
- Colarusso, Sara
- Piscopo, Marco
- Improta, Maria Rosaria
- Corigliano, Marco
- Martedi, Emilia
- Oliva, Domenica
- Russo, Viviana
- Simonetti, Rosa
- Satta, Ersilia
- Romano, Carmine
- Vaia, Sebastiano
- Strollo, Felice
- SpringerLink (Online service)
Ähnliche Objekte (12)
Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study
Thyroid disease in insulin-treated patients with type 2 diabetes : a retrospective study
Identifying and treating hypoglycemia in insulin-treated diabetes
Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Insulin, sulphonylurea : combination therapy in type II diabetes
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study
Thyroid disease in insulin-treated patients with type 2 diabetes : a retrospective study
Identifying and treating hypoglycemia in insulin-treated diabetes
Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Insulin, sulphonylurea : combination therapy in type II diabetes
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study
Thyroid disease in insulin-treated patients with type 2 diabetes : a retrospective study
Identifying and treating hypoglycemia in insulin-treated diabetes
Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Insulin, sulphonylurea : combination therapy in type II diabetes